These rats' elevated circulating levels of IL-6 could in turn stimulate a greater release of NA through the activation of the SNS, and the two molecules together (in a dysregulated interaction in MS) would contribute to the observed higher glucose levels. The gene discussed is IL6; the disease is myeloid sarcoma.